Abel Hall »

Humacyte shares owned by Abel Hall

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Abel Hall

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6k 14k 0.61

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us High Profitab (DUHP)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Small Cap V (DISV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Humacyte

BlackRock
Vanguard Group
Vanguard Capital Management
Antipodes Partners
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
AQR Capital Management
Susquehanna International
Vanguard Portfolio Management
Charles Schwab Investment Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Humacyte